Hyperion DeFi | 10-Q: FY2025 Q2 Revenue Misses Estimate at USD 0

LB filings
2025.08.13 20:08
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q2, the actual value is USD 0, missing the estimate of USD 600 K.

EPS: As of FY2025 Q2, the actual value is USD -2.5.

Segment Revenue

  • Revenue: $14,720 for the six months ended June 30, 2025, compared to $27,618 for the same period in 2024.

Operational Metrics

  • Net Loss: - $12,174,452 for the six months ended June 30, 2025, compared to - $21,975,800 for the same period in 2024.
  • Gross Profit (Loss): $14,672 for the six months ended June 30, 2025, compared to - $665,770 for the same period in 2024.
  • Research and Development Expenses: $1,347,621 for the six months ended June 30, 2025, compared to $9,028,774 for the same period in 2024.
  • Selling, General and Administrative Expenses: $10,051,026 for the six months ended June 30, 2025, compared to $7,396,024 for the same period in 2024.
  • Reacquisition of License Rights: $0 for the six months ended June 30, 2025, compared to $4,864,600 for the same period in 2024.

Cash Flow

  • Net Cash Used in Operating Activities: - $7,889,797 for the six months ended June 30, 2025, compared to - $18,066,228 for the same period in 2024.
  • Net Cash Used in Investing Activities: - $45,522,959 for the six months ended June 30, 2025, compared to - $159,853 for the same period in 2024.
  • Net Cash Provided by Financing Activities: $58,823,584 for the six months ended June 30, 2025, compared to $5,677,876 for the same period in 2024.

Unique Metrics

  • HYPE Digital Tokens: Purchased a total of 1,306,452 HYPE digital tokens at a total cost of $45.5 million in June 2025.

Future Outlook and Strategy

  • Core Business Focus: Hyperion DeFi plans to continue the development and registration of its Optejet ophthalmic liquid delivery device, with anticipated registration by the U.S. Food and Drug Administration this year.
  • Non-Core Business: The company is building a long-term strategic treasury of HYPE digital tokens, aiming to benefit from the Hyperliquid ecosystem’s growth and revenue generation.
  • Priority: The company expects to alleviate substantial doubt about its ability to continue as a going concern by reducing operating expenses, raising additional funds through future financings, and potentially selling HYPE digital tokens to fund operations.